FDA Clears QIAGEN's Gram-Negative QIAstat-Dx Bloodstream Panel, Joining Gram-Positive And Fungal Panel To Cover 33 Pathogen Targets And 28 Resistance Marker
Qiagen N.V. (QGEN) Presents at Berenberg and Goldman Sachs 15th German Corporate Conference 2026 - Slideshow (NYSE:QGEN) 2026-09-21